Abstract
The partially cyclized μ/ν-carrageenan 1C3, isolated from the red seaweed Gigartina skottsbergii , was previously shown to be a potent inhibitor of the in vitro replication of Herpes simplex virus types 1 (HSV-1) and 2 (HSV-2). Here the protective effect of 1C3 in a murine model of intraperitoneal (i. p. ) HSV-1 infection was evaluated. OF1 mice were i. p. infected with 5 × 105 PFU of HSV-1 KOS strain, and the effects of different treatments with 1C3 were studied. When 30 mg/kg of body weight of 1C3 was administered by the i. p. route immediately after HSV-1 infection, 87.5 % survival of the animals was achieved (p < 0.005), associated with a delay in the mean day of death in 1C3-treated non-surviving mice. Animal survival was not improved when multiple doses of 1C3 were also given in the period 1 - 48 h post-infection, and no protection was afforded when treatment was started after 24 h of infection. When virus and compound were injected by different routes, i. p. and intravenous (i. v. ), respectively, a still significant protection was achieved (40 % survival, p < 0.05). No toxicity of 1C3 for the animals was recorded. The pharmacokinetic properties were analyzed after injection of 1C3 into the tail vein by monitoring of [3
H ]-1C3 in plasma and organs and by a bioassay of the anti-HSV-1 activity remaining in serum after non-radioactive 1C3 inoculation. A very rapid disappearance of the compound from the blood was observed since only 5.9 - 0.9 % of the radioactivity of the initially administered [3
H ]-1C3 appeared in the plasma between 5 - 300 minutes after administration. A transient peak of radioactivity was detected in the kidney 15 minutes after inoculation. The bioassay confirms the presence of the compound circulating in a biologically active form up to 1 hour after injection.
Key words
antiviral agent -
Herpes simplex virus - natural carrageenan - mouse intraperitoneal infection - pharmacokinetics -
Gigartina skottsbergii
- Gigartinaceae - Gigartinales
References
Viva-Natural , a dietary seaweed extract, on Rauscher murine leukemia in comparison with anti-HIV agents, azidothymidine, dextran sulfate and pentosan polysulfate.
Cancer Lett.
1991;
56
197-20
in vitro and in vivo
.
Antiviral Chem Chemother.
1993;
4
189-91
Herpes simplex virus infection.
Clin Diagn Lab Immunol.
1997;
4
465-8
in vitro and in vivo activity against herpes simplex virus type 2.
Antiviral Res.
1999;
42
219-26
herpes simplex virus infection in mice.
Antiviral Res.
2004;
64
137-41
Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity.
Int J Biol Macromol.
1997;
20
97-105
Herpes simplex virus infection of mouse astrocytes.
Chemotherapy.
1999;
45
429-36
Herpes simplex virus glycoprotein gC with mammalian cell surface molecules.
J Virol.
1995;
69
4471-83
Gigartina skottsbergii
.
Phytochemistry.
1989;
28
2937-41
Gigartina skottsbergii by methylation analysis and NMR spectroscopy.
Carbohydr Res.
1993;
238
241-8
N -linked carbohydrate chain of the 85-kilodalton glycoprotein from Trypanosoma cruzi trypomastigotes contains sialyl, fucosyl and galactosyl(α-1 - 3)galactose units.
Mol Biochem Parasitol.
1990;
39
101-8
Spirulina platensis : in vitro and ex vivo evaluation of anti-Herpes simplex virus and anti-human immunodeficiency virus activities.
AIDS Res Hum Retroviruses.
1996;
12
1463-71
capujol@qb.fcen.uba.ar
